Td Asset Management Inc Lian Bio Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$1.49 - $2.46 $265,993 - $439,156
178,519 Added 100.0%
357,038 $531,000
Q3 2022

Nov 07, 2022
BUY
$1.87 - $3.0 $44,132 - $70,800
23,600 Added 15.23%
178,519 $359,000
Q4 2021

Feb 10, 2022
BUY
$6.14 - $16.2 $951,202 - $2.51 Million
154,919 New
154,919 $954,000

Others Institutions Holding LIAN

# of Institutions
3
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email